1. Home
  2. RDHL vs YGMZ Comparison

RDHL vs YGMZ Comparison

Compare RDHL & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • YGMZ
  • Stock Information
  • Founded
  • RDHL 2009
  • YGMZ 2002
  • Country
  • RDHL Israel
  • YGMZ China
  • Employees
  • RDHL N/A
  • YGMZ N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • YGMZ Transportation Services
  • Sector
  • RDHL Health Care
  • YGMZ Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • YGMZ Nasdaq
  • Market Cap
  • RDHL 6.8M
  • YGMZ 7.0M
  • IPO Year
  • RDHL N/A
  • YGMZ 2020
  • Fundamental
  • Price
  • RDHL $4.76
  • YGMZ $0.72
  • Analyst Decision
  • RDHL
  • YGMZ
  • Analyst Count
  • RDHL 0
  • YGMZ 0
  • Target Price
  • RDHL N/A
  • YGMZ N/A
  • AVG Volume (30 Days)
  • RDHL 9.0K
  • YGMZ 44.8K
  • Earning Date
  • RDHL 04-07-2025
  • YGMZ 01-01-0001
  • Dividend Yield
  • RDHL N/A
  • YGMZ N/A
  • EPS Growth
  • RDHL N/A
  • YGMZ N/A
  • EPS
  • RDHL N/A
  • YGMZ N/A
  • Revenue
  • RDHL $3,707,000.00
  • YGMZ $55,805,416.00
  • Revenue This Year
  • RDHL $224.90
  • YGMZ N/A
  • Revenue Next Year
  • RDHL $82.69
  • YGMZ N/A
  • P/E Ratio
  • RDHL N/A
  • YGMZ N/A
  • Revenue Growth
  • RDHL N/A
  • YGMZ N/A
  • 52 Week Low
  • RDHL $4.76
  • YGMZ $0.64
  • 52 Week High
  • RDHL $20.28
  • YGMZ $6.24
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 26.11
  • YGMZ 44.09
  • Support Level
  • RDHL $5.20
  • YGMZ $0.68
  • Resistance Level
  • RDHL $5.50
  • YGMZ $1.05
  • Average True Range (ATR)
  • RDHL 0.23
  • YGMZ 0.11
  • MACD
  • RDHL -0.07
  • YGMZ -0.00
  • Stochastic Oscillator
  • RDHL 0.00
  • YGMZ 19.66

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.

Share on Social Networks: